Middle East Veterinary Vaccines Market : TOC


Middle East Veterinary Vaccines Market

Veterinary Vaccines Market: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026

  • REP-MA-3086
  • 2017-03-02
  • 176 Pages
  • Format: pdf ppt
  • Category: Healthcare, Pharmaceuticals and Medical devices

Table Of Content

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3. Middle East Veterinary Vaccines Market Analysis Scenario

3.1. Market Size (US$ Mn) and Forecast

3.1.1. Market Size and Y-o-Y Growth

3.1.2. Absolute $ Opportunity

3.2. Market Overview

3.2.1. Value Chain

4. Market Dynamics and USPs

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5.Standard Approval Process U.S.

4.6.Vaccines Labelling Requirements

4.7.Scenario of Local Manufacturing and Veterinary Vaccine Registration

4.8.Veterinary Medical Product Registration Timelines and Products

5. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Vaccine Type 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Vaccine Type 

5.3. Y-o-Y Growth Projections By Vaccine Type 

5.4. Market Value Forecast By Vaccine Type, 2016–2026

5.4.1. Live Attenuated Vaccines

5.4.2. Killed/Inactive Vaccines

5.4.3. Recombinant Vaccines

5.4.4. DNA Vaccines

5.4.5. Toxoid Vaccines

5.4.6. Others

5.5. Market Attractiveness By Vaccine Type 

6. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Animal Type 

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Animal Type 

6.3. Y-o-Y Growth Projections By Animal Type 

6.4. Market Value Forecast By Animal Type, 2016–2026

6.4.1. Companion Animal 

6.4.1.1. Canine

6.4.1.2. Feline

6.4.1.3. Avian (Ornamental Bird)

6.4.2. Livestock Animal 

6.4.2.1. Aquatic

6.4.2.2. Bovine

6.4.2.3. Porcine

6.4.2.4. Small Ruminant

6.4.2.5. Poultry

6.4.3. Equine

6.5. Market Attractiveness By Animal Type 

7. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Disease Indication 

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By Disease Indication 

7.3. Y-o-Y Growth Projections By Disease Indication 

7.4. Market Value Forecast By Disease Indication, 2016–2026

7.4.1. Foot and Mouth Diseases

7.4.2. Avian Influenza

7.4.3. New Castle Disease 

7.4.4. PPRS

7.4.5. Brucellosis

7.4.6. Canine Parvovirus

7.4.7. Others

7.5. Market Attractiveness By Disease Indication 

8. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Distribution Channel 

8.1. Introduction

8.2. Basis Point Share (BPS) Analysis By Distribution Channel 

8.3. Y-o-Y Growth Projections By Distribution Channel 

8.4. Market Value Forecast By Distribution Channel, 2016–2026

8.4.1. Hospital Pharmacies

8.4.2. Veterinary Clinics

8.4.3. Private Veterinary Pharmacies

8.4.4. Others ( Research Institutes, Laboratories) 

8.5. Market Attractiveness By Distribution Channel 

9. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Country

9.1. Basis Point Share (BPS) Analysis By Country

9.2. Y-o-Y Growth Projections By Country

9.3. Market Value Forecast By Country

9.3.1. UAE

9.3.2. KSA

9.3.3. Turkey

9.3.4. Jordan

9.3.5. Sudan

9.3.6. Egypt

9.3.7. Rest of MEA

9.4. Market Attractiveness By Country

10. UAE Veterinary Vaccines Market Analysis and Forecast

10.1.Market Value Forecast By Vaccine Type, 2016–2026

10.1.1. Live Attenuated Vaccines

10.1.2. Killed/Inactive Vaccines

10.1.3. Recombinant Vaccines

10.1.4. DNA Vaccines

10.1.5. Toxoid Vaccines

10.1.6. Others

10.2.Market Value Forecast By Disease Indication, 2016–2026

10.2.1. Foot and Mouth Diseases

10.2.2. Avian Influenza

10.2.3. New Castle Disease 

10.2.4. PPRS

10.2.5. Brucellosis

10.2.6. Canine Parvovirus

10.2.7. Others

10.3.Market Value Forecast By Animal Type, 2016–2026

10.3.1. Companion Animal 

10.3.1.1. Canine

10.3.1.2. Feline

10.3.1.3. Avian (Ornamental Bird)

10.3.2. Livestock Animal 

10.3.2.1. Aquatic

10.3.2.2. Bovine

10.3.2.3. Porcine

10.3.2.4. Small Ruminant

10.3.2.5. Poultry

10.3.3. Equine

10.4.Market Value Forecast By Distribution Channel, 2016–2026

10.4.1. Hospital Pharmacies

10.4.2. Veterinary Clinics

10.4.3. Private Veterinary Pharmacies

10.4.4. Others ( Research Institutes, Laboratories) 

11. KSA Veterinary Vaccines Market Analysis and Forecast

11.1.Market Value Forecast By Vaccine Type, 2016–2026

11.1.1. Live Attenuated Vaccines

11.1.2. Killed/Inactive Vaccines

11.1.3. Recombinant Vaccines

11.1.4. DNA Vaccines

11.1.5. Toxoid Vaccines

11.1.6. Others

11.2.Market Value Forecast By Disease Indication, 2016–2026

11.2.1. Foot and Mouth Diseases

11.2.2. Avian Influenza

11.2.3. New Castle Disease 

11.2.4. PPRS

11.2.5. Brucellosis

11.2.6. Canine Parvovirus

11.2.7. Others

11.3.Market Value Forecast By Animal Type, 2016–2026

11.3.1. Companion Animal 

11.3.1.1. Canine

11.3.1.2. Feline

11.3.1.3. Avian (Ornamental Bird)

11.3.2. Livestock Animal 

11.3.2.1. Aquatic

11.3.2.2. Bovine

11.3.2.3. Porcine

11.3.2.4. Small Ruminant

11.3.2.5. Poultry

11.3.3. Equine

11.4.Market Value Forecast By Distribution Channel, 2016–2026

11.4.1. Hospital Pharmacies

11.4.2. Veterinary Clinics

11.4.3. Private Veterinary Pharmacies

11.4.4. Others ( Research Institutes, Laboratories) 

12. Turkey Veterinary Vaccines Market Analysis and Forecast

12.1.Market Value Forecast By Vaccine Type, 2016–2026

12.1.1. Live Attenuated Vaccines

12.1.2. Killed/Inactive Vaccines

12.1.3. Recombinant Vaccines

12.1.4. DNA Vaccines

12.1.5. Toxoid Vaccines

12.1.6. Others

12.2.Market Value Forecast By Disease Indication, 2016–2026

12.2.1. Foot and Mouth Diseases

12.2.2. Avian Influenza

12.2.3. New Castle Disease 

12.2.4. PPRS

12.2.5. Brucellosis

12.2.6. Canine Parvovirus

12.2.7. Others

12.3.Market Value Forecast By Animal Type, 2016–2026

12.3.1. Companion Animal 

12.3.1.1. Canine

12.3.1.2. Feline

12.3.1.3. Avian (Ornamental Bird)

12.3.2. Livestock Animal 

12.3.2.1. Aquatic

12.3.2.2. Bovine

12.3.2.3. Porcine

12.3.2.4. Small Ruminant

12.3.2.5. Poultry

12.3.3. Equine

12.4.Market Value Forecast By Distribution Channel, 2016–2026

12.4.1. Hospital Pharmacies

12.4.2. Veterinary Clinics

12.4.3. Private Veterinary Pharmacies

12.4.4. Others ( Research Institutes, Laboratories) 

13. Jordan Veterinary Vaccines Market Analysis and Forecast

13.1.Market Value Forecast By Vaccine Type, 2016–2026

13.1.1. Live Attenuated Vaccines

13.1.2. Killed/Inactive Vaccines

13.1.3. Recombinant Vaccines

13.1.4. DNA Vaccines

13.1.5. Toxoid Vaccines

13.1.6. Others

13.2.Market Value Forecast By Disease Indication, 2016–2026

13.2.1. Foot and Mouth Diseases

13.2.2. Avian Influenza

13.2.3. New Castle Disease 

13.2.4. PPRS

13.2.5. Brucellosis

13.2.6. Canine Parvovirus

13.2.7. Others

13.3.Market Value Forecast By Animal Type, 2016–2026

13.3.1. Companion Animal 

13.3.1.1. Canine

13.3.1.2. Feline

13.3.1.3. Avian (Ornamental Bird)

13.3.2. Livestock Animal 

13.3.2.1. Aquatic

13.3.2.2. Bovine

13.3.2.3. Porcine

13.3.2.4. Small Ruminant

13.3.2.5. Poultry

13.3.3. Equine

13.4.Market Value Forecast By Distribution Channel, 2016–2026

13.4.1. Hospital Pharmacies

13.4.2. Veterinary Clinics

13.4.3. Private Veterinary Pharmacies

13.4.4. Others ( Research Institutes, Laboratories) 

14. Sudan Veterinary Vaccines Market Analysis and Forecast

14.1.Market Value Forecast By Vaccine Type, 2016–2026

14.1.1. Live Attenuated Vaccines

14.1.2. Killed/Inactive Vaccines

14.1.3. Recombinant Vaccines

14.1.4. DNA Vaccines

14.1.5. Toxoid Vaccines

14.1.6. Others

14.2.Market Value Forecast By Disease Indication, 2016–2026

14.2.1. Foot and Mouth Diseases

14.2.2. Avian Influenza

14.2.3. New Castle Disease 

14.2.4. PPRS

14.2.5. Brucellosis

14.2.6. Canine Parvovirus

14.2.7. Others

14.3.Market Value Forecast By Animal Type, 2016–2026

14.3.1. Companion Animal 

14.3.1.1. Canine

14.3.1.2. Feline

14.3.1.3. Avian (Ornamental Bird)

14.3.2. Livestock Animal 

14.3.2.1. Aquatic

14.3.2.2. Bovine

14.3.2.3. Porcine

14.3.2.4. Small Ruminant

14.3.2.5. Poultry

14.3.3. Equine

14.4.Market Value Forecast By Distribution Channel, 2016–2026

14.4.1. Hospital Pharmacies

14.4.2. Veterinary Clinics

14.4.3. Private Veterinary Pharmacies

14.4.4. Others ( Research Institutes, Laboratories) 

15. Egypt Veterinary Vaccines Market Analysis and Forecast

15.1.Market Value Forecast By Vaccine Type, 2016–2026

15.1.1. Live Attenuated Vaccines

15.1.2. Killed/Inactive Vaccines

15.1.3. Recombinant Vaccines

15.1.4. DNA Vaccines

15.1.5. Toxoid Vaccines

15.1.6. Others

15.2.Market Value Forecast By Disease Indication, 2016–2026

15.2.1. Foot and Mouth Diseases

15.2.2. Avian Influenza

15.2.3. New Castle Disease 

15.2.4. PPRS

15.2.5. Brucellosis

15.2.6. Canine Parvovirus

15.2.7. Others

15.3.Market Value Forecast By Animal Type, 2016–2026

15.3.1. Companion Animal 

15.3.1.1. Canine

15.3.1.2. Feline

15.3.1.3. Avian (Ornamental Bird)

15.3.2. Livestock Animal 

15.3.2.1. Aquatic

15.3.2.2. Bovine

15.3.2.3. Porcine

15.3.2.4. Small Ruminant

15.3.2.5. Poultry

15.3.3. Equine

15.4.Market Value Forecast By Distribution Channel, 2016–2026

15.4.1. Hospital Pharmacies

15.4.2. Veterinary Clinics

15.4.3. Private Veterinary Pharmacies

15.4.4. Others ( Research Institutes, Laboratories) 

16. Rest of MEA Veterinary Vaccines Market Analysis and Forecast

16.1.Market Value Forecast By Vaccine Type, 2016–2026

16.1.1. Live Attenuated Vaccines

16.1.2. Killed/Inactive Vaccines

16.1.3. Recombinant Vaccines

16.1.4. DNA Vaccines

16.1.5. Toxoid Vaccines

16.1.6. Others

16.2.Market Value Forecast By Disease Indication, 2016–2026

16.2.1. Foot and Mouth Diseases

16.2.2. Avian Influenza

16.2.3. New Castle Disease 

16.2.4. PPRS

16.2.5. Brucellosis

16.2.6. Canine Parvovirus

16.2.7. Others

16.3.Market Value Forecast By Animal Type, 2016–2026

16.3.1. Companion Animal 

16.3.1.1. Canine

16.3.1.2. Feline

16.3.1.3. Avian (Ornamental Bird)

16.3.2. Livestock Animal 

16.3.2.1. Aquatic

16.3.2.2. Bovine

16.3.2.3. Porcine

16.3.2.4. Small Ruminant

16.3.2.5. Poultry

16.3.3. Equine

16.4.Market Value Forecast By Distribution Channel, 2016–2026

16.4.1. Hospital Pharmacies

16.4.2. Veterinary Clinics

16.4.3. Private Veterinary Pharmacies

16.4.4. Others ( Research Institutes, Laboratories) 

17. Competition Landscape

17.1. Competition Dashboard

17.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

17.2.1. JOVAC 

17.2.2. Bioveta, Inc. 

17.2.3. Intervac Pvt. Ltd.

17.2.4. Zoetis 

17.2.5. Elanco 

17.2.6. Merial 

17.2.7. Merck & Co., Inc. 

17.2.8. Bayer Pharma AG 

17.2.9. Ceva 

18. Assumptions and Acronyms Used

19. Research Methodology

List of Tables

Table 1: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 2: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 3: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 4: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 5: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026

Table 6: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 7: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 8: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 9: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 10: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 11: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 12: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 13: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 14: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 15: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 16: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 17: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 18: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 19: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 20: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 21: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 22: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 23: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 24: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 25: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 26: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 27: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 28: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 29: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 30: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 31: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 32: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 33: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

List of Figures

Figure 01: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast 2016 and 2026

Figure 02: Middle East Veterinary Vaccines Market Value Share, By Vaccine Type, 2016

Figure 03: Middle East Veterinary Vaccines Market Value Share, By Animal Type, 2016

Figure 04: Middle East Veterinary Vaccines Market Value Share, By Disease Indication, 2016

Figure 05: Middle East Veterinary Vaccines Market Value Share, By End User, 2016

Figure 06: Middle East Veterinary Vaccines Market Value Share, By Country, 2016

Figure 07: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast, 2015–2026 

Figure 08: Middle East Veterinary Vaccines Market Absolute $ Opportunity, 2015–2026 

Figure 09: Middle East Veterinary Vaccines Market Y-o-Y Growth, 2015–2026 

Figure 10: Middle East Veterinary Vaccines Market Share Analysis (%) By Vaccine Type, 2016 & 2026

Figure 11: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Vaccine Type, 2015–2026 

Figure 12: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Attenuated Live Vaccines Segment, 2015 – 2026

Figure 13: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Inactivated Vaccines Segment, 2015 – 2026

Figure 14: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccine Segment, 2015 – 2026

Figure 15: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By DNA Vaccine Segment, 2015 – 2026

Figure 16: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) Recombinant Vaccines s Segment, 2015 – 2026

Figure 17: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026

Figure 18: Middle East Veterinary Vaccines Market Attractiveness Analysis By Vaccine Type, 2016–2026 

Figure 19: Middle East Veterinary Vaccines Market Share Analysis (%) By Animal Type, 2016 & 2026

Figure 20: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Animal Type, 2015–2026 

Figure 21: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Companion Animals Segment, 2015 – 2026

Figure 22: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Livestock Animals Segment, 2015 – 2026

Figure 23: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Equine Segment, 2015 – 2026

Figure 24: Middle East Veterinary Vaccines Market Attractiveness Analysis By Animal Type, 2016–2026 

Figure 25: Middle East Veterinary Vaccines Market Share Analysis (%) By Disease Indication, 2020 & 2026

Figure 26: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Disease Indication, 2015–2026 

Figure 27: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Foot and Mouth Disease  Segment, 2015 – 2026

Figure 28: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By New Castle Disease Segment, 2015 – 2026

Figure 29: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By PPRS Segment, 2015 – 2026

Figure 30: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Canine Parvovirus Segment, 2015 – 2026

Figure 31: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Brucellosis Segment, 2015 – 2026

Figure 32: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Avian Influenza Segment, 2015 – 2026

Figure 33: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026

Figure 34: Middle East Veterinary Vaccines Market Attractiveness Analysis By Disease Indication, 2016–2026 

Figure 35: Middle East Veterinary Vaccines Market Share Analysis (%) By End User, 2020 & 2026

Figure 36: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By End User, 2015–2026 

Figure 37: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Hospital Pharmacies Segment, 2015 – 2026

Figure 38: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics  Segment, 2015 – 2026

Figure 39: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Private Veterinary Pharmacies  Segment, 2015 – 2026

Figure 40: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026

Figure 41: Middle East Veterinary Vaccines Market Attractiveness Analysis By End User, 2016–2026 

Figure 42: Middle East Veterinary Vaccines Market Share Analysis (%) By Country, 2016 & 2026

Figure 43: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 44: UAE Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),

Figure 45: KSA Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),

Figure 46: Turkey Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 47: Jordan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 48: Sudan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 49: Egypt Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 50: Rest of MEA

Figure 51: Middle East Veterinary Vaccines Market Attractiveness Analysis By Country, 2016–2026